🇺🇸 FDA
Patent

US 8563269

Modified antibody compositions, methods of making and using thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 8563269 (Modified antibody compositions, methods of making and using thereof) held by CytomX Therapeutics, Inc. expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K47/6845